Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 76

1.

Bonding Insights from Structural and Spectroscopic Comparisons of {SnW5 } and {TiW5 } Alkoxido- and Aryloxido-Substituted Lindqvist Polyoxometalates.

Kandasamy B, Bruce PG, Clegg W, Harrington RW, Rodríguez-Fortea A, Pascual-Borrás M, Errington RJ.

Chemistry. 2018 Feb 21;24(11):2750-2757. doi: 10.1002/chem.201705547. Epub 2018 Jan 29.

PMID:
29315880
2.

The unidirectional hypoxia-activated prodrug OCT1002 inhibits growth and vascular development in castrate-resistant prostate tumors.

Nesbitt H, Worthington J, Errington RJ, Patterson LH, Smith PJ, McKeown SR, McKenna DJ.

Prostate. 2017 Nov;77(15):1539-1547. doi: 10.1002/pros.23434. Epub 2017 Sep 24.

PMID:
28944496
3.

Targeting protein homeostasis with nelfinavir/salinomycin dual therapy effectively induces death of mTORC1 hyperactive cells.

Dunlop EA, Johnson CE, Wiltshire M, Errington RJ, Tee AR.

Oncotarget. 2017 Jul 25;8(30):48711-48724. doi: 10.18632/oncotarget.16232.

4.

Targeting Hypoxic Prostate Tumors Using the Novel Hypoxia-Activated Prodrug OCT1002 Inhibits Expression of Genes Associated with Malignant Progression.

Nesbitt H, Byrne NM, Williams SN, Ming L, Worthington J, Errington RJ, Patterson LH, Smith PJ, McKeown SR, McKenna DJ.

Clin Cancer Res. 2017 Apr 1;23(7):1797-1808. doi: 10.1158/1078-0432.CCR-16-1361. Epub 2016 Oct 3.

PMID:
27697998
5.

A multi-stage random forest classifier for phase contrast cell segmentation.

Essa E, Xie X, Errington RJ, White N.

Conf Proc IEEE Eng Med Biol Soc. 2015;2015:3865-8. doi: 10.1109/EMBC.2015.7319237.

PMID:
26737137
6.

Tracking the Cyclin B1-GFP Sensor to Profile the Pattern of Mitosis Versus Mitotic Bypass.

Griesdoorn V, Brown MR, Wiltshire M, Smith PJ, Errington RJ.

Methods Mol Biol. 2016;1342:279-85. doi: 10.1007/978-1-4939-2957-3_17.

PMID:
26254931
7.

A 3D ex vivo mandible slice system for longitudinal culturing of transplanted dental pulp progenitor cells.

Colombo JS, Howard-Jones RA, Young FI, Waddington RJ, Errington RJ, Sloan AJ.

Cytometry A. 2015 Oct;87(10):921-8. doi: 10.1002/cyto.a.22680. Epub 2015 May 11.

8.

Endoplasmic reticulum stress and cell death in mTORC1-overactive cells is induced by nelfinavir and enhanced by chloroquine.

Johnson CE, Hunt DK, Wiltshire M, Herbert TP, Sampson JR, Errington RJ, Davies DM, Tee AR.

Mol Oncol. 2015 Mar;9(3):675-88. doi: 10.1016/j.molonc.2014.11.005. Epub 2014 Nov 22.

9.

Synthesis and characterization of the platinum-substituted Keggin anion α-H2SiPtW11O40(4-).

Klonowski P, Goloboy JC, Uribe-Romo FJ, Sun F, Zhu L, Gándara F, Wills C, Errington RJ, Yaghi OM, Klemperer WG.

Inorg Chem. 2014 Dec 15;53(24):13239-46. doi: 10.1021/ic502617k. Epub 2014 Nov 19.

PMID:
25409288
10.

ProtocolNavigator: emulation-based software for the design, documentation and reproduction biological experiments.

Khan IA, Fraser A, Bray MA, Smith PJ, White NS, Carpenter AE, Errington RJ.

Bioinformatics. 2014 Dec 1;30(23):3440-2. doi: 10.1093/bioinformatics/btu554. Epub 2014 Aug 22.

11.

Human basal cell carcinoma tumor-initiating cells are resistant to etoposide.

Colmont CS, Ketah AB, Errington RJ, Reed SH, Udey MC, Patel GK.

J Invest Dermatol. 2014 Mar;134(3):867-870. doi: 10.1038/jid.2013.377. Epub 2013 Sep 11. No abstract available.

12.

A redox-triggered structural rearrangement in an iodate-templated polyoxotungstate cluster cage.

Long DL, Yan J, Ruiz de la Oliva A, Busche C, Miras HN, Errington RJ, Cronin L.

Chem Commun (Camb). 2013 Oct 28;49(84):9731-3. doi: 10.1039/c3cc45659e.

PMID:
24022579
13.

Pharmacological inhibition of polysialyltransferase ST8SiaII modulates tumour cell migration.

Al-Saraireh YM, Sutherland M, Springett BR, Freiberger F, Ribeiro Morais G, Loadman PM, Errington RJ, Smith PJ, Fukuda M, Gerardy-Schahn R, Patterson LH, Shnyder SD, Falconer RA.

PLoS One. 2013 Aug 9;8(8):e73366. doi: 10.1371/journal.pone.0073366. eCollection 2013.

14.

BH3 helix-derived biophotonic nanoswitches regulate cytochrome c release in permeabilised cells.

Mart RJ, Errington RJ, Watkins CL, Chappell SC, Wiltshire M, Jones AT, Smith PJ, Allemann RK.

Mol Biosyst. 2013 Nov;9(11):2597-603. doi: 10.1039/c3mb70246d.

PMID:
23942570
15.

Micro-community cytometry: sensing changes in cell health and glycoconjugate expression by imaging and flow cytometry.

Smith PJ, Falconer RA, Errington RJ.

J Microsc. 2013 Aug;251(2):113-22. doi: 10.1111/jmi.12060. Epub 2013 Jun 13. Review.

16.

NCAM polysialylation during adherence transitions: live cell monitoring using an antibody-mimetic EGFP-endosialidase and the viability dye DRAQ7.

Smith PJ, Furon E, Wiltshire M, Chappell S, Patterson LH, Shnyder SD, Falconer RA, Errington RJ.

Cytometry A. 2013 Jul;83(7):659-71. doi: 10.1002/cyto.a.22306. Epub 2013 May 28.

17.

Time-lapse microscopy approaches to track cell cycle and lineage progression at the single-cell level.

Errington RJ, Chappell SC, Khan IA, Marquez N, Wiltshire M, Griesdoorn VD, Smith PJ.

Curr Protoc Cytom. 2013 Apr;Chapter 12:Unit12.4. doi: 10.1002/0471142956.cy1204s64.

PMID:
23546776
18.

Kinetic analysis of intracellular Hoechst 33342--DNA interactions by flow cytometry: misinterpretation of side population status?

Smith PJ, Wiltshire M, Chappell SC, Cosentino L, Burns PA, Pors K, Errington RJ.

Cytometry A. 2013 Jan;83(1):161-9. doi: 10.1002/cyto.a.22224. Epub 2012 Nov 7.

19.

Automated cell identification and tracking using nanoparticle moving-light-displays.

Tonkin JA, Rees P, Brown MR, Errington RJ, Smith PJ, Chappell SC, Summers HD.

PLoS One. 2012;7(7):e40835. doi: 10.1371/journal.pone.0040835. Epub 2012 Jul 19.

20.

Polysialyltransferase: a new target in metastatic cancer.

Falconer RA, Errington RJ, Shnyder SD, Smith PJ, Patterson LH.

Curr Cancer Drug Targets. 2012 Oct;12(8):925-39. Review.

PMID:
22463390
21.

Rational addition of capping groups to the phosphomolybdate Keggin anion [PMo12O40](3-) by mild, non-aqueous reductive aggregation.

Bakri R, Booth A, Harle G, Middleton PS, Wills C, Clegg W, Harrington RW, Errington RJ.

Chem Commun (Camb). 2012 Mar 14;48(22):2779-81. doi: 10.1039/c2cc17670j. Epub 2012 Feb 7.

PMID:
22314688
22.

An alkoxido-tin-substituted polyoxometalate [(MeO)SnW5O18]3-: the first member of a new family of reactive {SnW5} Lindqvist-type anions.

Kandasamy B, Wills C, McFarlane W, Clegg W, Harrington RW, Rodríguez-Fortea A, Poblet JM, Bruce PG, Errington RJ.

Chemistry. 2012 Jan 2;18(1):59-62. doi: 10.1002/chem.201103544. Epub 2011 Dec 6. No abstract available.

PMID:
22147370
23.

Protonolysis of [((i)PrO)TiMo5O18]3-: access to a family of TiMo5 Lindqvist type polyoxometalates.

Coyle L, Middleton PS, Murphy CJ, Clegg W, Harrington RW, Errington RJ.

Dalton Trans. 2012 Jan 21;41(3):971-81. doi: 10.1039/c1dt11256b. Epub 2011 Nov 18.

PMID:
22095163
24.

Chemical synthesis of cell-permeable apoptotic peptides from in vivo produced proteins.

Fricke T, Mart RJ, Watkins CL, Wiltshire M, Errington RJ, Smith PJ, Jones AT, Allemann RK.

Bioconjug Chem. 2011 Sep 21;22(9):1763-7. doi: 10.1021/bc200338u. Epub 2011 Aug 15.

PMID:
21823633
25.

A transfer function approach to measuring cell inheritance.

Rees P, Brown MR, Summers HD, Holton MD, Errington RJ, Chappell SC, Smith PJ.

BMC Syst Biol. 2011 Feb 22;5:31. doi: 10.1186/1752-0509-5-31.

26.

Interoperability of time series cytometric data: a cross platform approach for modeling tumor heterogeneity.

Khan IA, Lupi M, Campbell L, Chappell SC, Brown MR, Wiltshire M, Smith PJ, Ubezio P, Errington RJ.

Cytometry A. 2011 Mar;79(3):214-26. doi: 10.1002/cyto.a.21023. Epub 2011 Feb 18.

27.

Long-term time series analysis of quantum dot encoded cells by deconvolution of the autofluorescence signal.

Brown MR, Summers HD, Rees P, Chappell SC, Silvestre OF, Khan IA, Smith PJ, Errington RJ.

Cytometry A. 2010 Oct;77(10):925-32. doi: 10.1002/cyto.a.20936.

28.

Statistical analysis of nanoparticle dosing in a dynamic cellular system.

Summers HD, Rees P, Holton MD, Brown MR, Chappell SC, Smith PJ, Errington RJ.

Nat Nanotechnol. 2011 Mar;6(3):170-4. doi: 10.1038/nnano.2010.277. Epub 2011 Jan 23.

PMID:
21258333
29.

Kinetic modelling of the role of the aldehyde dehydrogenase enzyme and the breast cancer resistance protein in drug resistance and transport.

Atari MI, Chappell MJ, Errington RJ, Smith PJ, Evans ND.

Comput Methods Programs Biomed. 2011 Nov;104(2):93-103. doi: 10.1016/j.cmpb.2010.06.008. Epub 2010 Jul 10.

PMID:
20621382
30.

Enhanced connexin 43 expression delays intra-mitotic duration and cell cycle traverse independently of gap junction channel function.

Johnstone SR, Best AK, Wright CS, Isakson BE, Errington RJ, Martin PE.

J Cell Biochem. 2010 Jun 1;110(3):772-82. doi: 10.1002/jcb.22590.

31.

Flow-based cytometric analysis of cell cycle via simulated cell populations.

Brown MR, Summers HD, Rees P, Smith PJ, Chappell SC, Errington RJ.

PLoS Comput Biol. 2010 Apr 15;6(4):e1000741. doi: 10.1371/journal.pcbi.1000741.

32.

Single cell nanoparticle tracking to model cell cycle dynamics and compartmental inheritance.

Errington RJ, Brown MR, Silvestre OF, Njoh KL, Chappell SC, Khan IA, Rees P, Wilks SP, Smith PJ, Summers HD.

Cell Cycle. 2010 Jan 1;9(1):121-30. Epub 2010 Jan 5.

PMID:
20016285
33.

ABCG2-associated resistance to Hoechst 33342 and topotecan in a murine cell model with constitutive expression of side population characteristics.

Smith PJ, Furon E, Wiltshire M, Campbell L, Feeney GP, Snyder RD, Errington RJ.

Cytometry A. 2009 Nov;75(11):924-33. doi: 10.1002/cyto.a.20800.

34.

Stroboscopic fluorescence lifetime imaging.

Holton MD, Silvestre OR, Errington RJ, Smith PJ, Matthews DR, Rees P, Summers HD.

Opt Express. 2009 Mar 30;17(7):5205-16.

PMID:
19333284
35.

Cytomics and cellular informatics--coping with asymmetry and heterogeneity in biological systems.

Smith PJ, Khan IA, Errington RJ.

Drug Discov Today. 2009 Mar;14(5-6):271-7. doi: 10.1016/j.drudis.2008.11.012. Epub 2009 Jan 15. Review.

PMID:
19150508
36.

Impact of overexpression of metallothionein-1 on cell cycle progression and zinc toxicity.

Smith PJ, Wiltshire M, Furon E, Beattie JH, Errington RJ.

Am J Physiol Cell Physiol. 2008 Nov;295(5):C1399-408. doi: 10.1152/ajpcell.00342.2008. Epub 2008 Sep 24.

37.

Time-lapse microscopy approaches to track cell cycle progression at the single-cell level.

Errington RJ, Marquez N, Chappell SC, Wiltshire M, Smith PJ.

Curr Protoc Cytom. 2005 Feb;Chapter 12:Unit 12.4. doi: 10.1002/0471142956.cy1204s31.

PMID:
18770815
38.

DRAQ5 labeling of nuclear DNA in live and fixed cells.

Smith PJ, Wiltshire M, Errington RJ.

Curr Protoc Cytom. 2004 May;Chapter 7:Unit 7.25. doi: 10.1002/0471142956.cy0725s28.

PMID:
18770802
39.

Exploration of the intercellular heterogeneity of topotecan uptake into human breast cancer cells through compartmental modelling.

Cheung SY, Evans ND, Chappell MJ, Godfrey KR, Smith PJ, Errington RJ.

Math Biosci. 2008 Jun;213(2):119-34. doi: 10.1016/j.mbs.2008.03.008. Epub 2008 Apr 4.

PMID:
18482740
40.

Cell cycle checkpoint-guarded routes to catenation-induced chromosomal instability.

Smith PJ, Chin SF, Njoh K, Khan IA, Chappell MJ, Errington RJ.

SEB Exp Biol Ser. 2008;59:219-42. No abstract available.

PMID:
18368926
41.

Development of FRET-based assays in the far-red using CdTe quantum dots.

Chong EZ, Matthews DR, Summers HD, Njoh KL, Errington RJ, Smith PJ.

J Biomed Biotechnol. 2007;2007(7):54169. doi: 10.1155/2007/54169.

42.

A coupled drug kinetics-cell cycle model to analyse the response of human cells to intervention by topotecan.

Chappell MJ, Evans ND, Errington RJ, Khan IA, Campbell L, Ali R, Godfrey KR, Smith PJ.

Comput Methods Programs Biomed. 2008 Feb;89(2):169-78. Epub 2007 Dec 20.

PMID:
18082908
43.

Non-aqueous synthetic methodology for TiW(5) polyoxometalates: protonolysis of [(MeO)TiW(5)O(18)](3-) with alcohols, water and phenols.

Errington RJ, Petkar SS, Middleton PS, McFarlane W, Clegg W, Coxall RA, Harrington RW.

Dalton Trans. 2007 Nov 28;(44):5211-22. Epub 2007 Sep 6.

PMID:
17985029
44.

Synthesis and reactivity of the methoxozirconium pentatungstate (nBu4N)6[{(mu-MeO)ZrW5O18}2]: insights into proton-transfer reactions, solution dynamics, and assembly of {ZrW5O18}2- building blocks.

Errington RJ, Petkar SS, Middleton PS, McFarlane W, Clegg W, Coxall RA, Harrington RW.

J Am Chem Soc. 2007 Oct 10;129(40):12181-96. Epub 2007 Sep 18.

PMID:
17877344
45.

Mitotic bypass via an occult cell cycle phase following DNA topoisomerase II inhibition in p53 functional human tumor cells.

Smith PJ, Marquez N, Wiltshire M, Chappell S, Njoh K, Campbell L, Khan IA, Silvestre O, Errington RJ.

Cell Cycle. 2007 Aug 15;6(16):2071-81. Epub 2007 Jun 16.

PMID:
17721081
46.

ProgeniDB: a novel cell lineage database for generation associated phenotypic behavior in cell-based assays.

Khan IA, Husemann P, Campbell L, White NS, White RJ, Smith PJ, Errington RJ.

Cell Cycle. 2007 Apr 1;6(7):868-74. Epub 2007 Apr 21.

PMID:
17387278
47.

Cytomics and drug development.

Smith PJ, Khan IA, Errington RJ.

Cytometry A. 2007 Jun;71(6):349-51. No abstract available.

48.

Spectral analysis of the DNA targeting bisalkylaminoanthraquinone DRAQ5 in intact living cells.

Njoh KL, Patterson LH, Zloh M, Wiltshire M, Fisher J, Chappell S, Ameer-Beg S, Bai Y, Matthews D, Errington RJ, Smith PJ.

Cytometry A. 2006 Aug 1;69(8):805-14.

49.

Technique for measurement of fluorescence lifetime by use of stroboscopic excitation and continuous-wave detection.

Matthews DR, Summers HD, Njoh K, Errington RJ, Smith PJ, Barber P, Ameer-Beg S, Vojnovic B.

Appl Opt. 2006 Mar 20;45(9):2115-23.

PMID:
16579582
50.

Covalent immobilization of a TiW5 polyoxometalate on derivatized silicon surfaces.

Errington RJ, Petkar SS, Horrocks BR, Houlton A, Lie LH, Patole SN.

Angew Chem Int Ed Engl. 2005 Feb 11;44(8):1254-7. No abstract available.

PMID:
15696586

Supplemental Content

Loading ...
Support Center